Revolutionizing Wastewater Testing with the ONETest™: A Powerful Tool for Early Detection of Infectious Diseases in Communities
Wastewater testing has emerged as a critical strategy for early disease surveillance, particularly in densely populated areas. Fusion Genomics introduces the ONETest™, a game-changing solution that leverages advanced genomic technology to revolutionize wastewater testing. With its unparalleled accuracy to detect all known and novel respiratory viruses, the ONETest™ provides invaluable insights for safeguarding public health, monitoring infectious disease outbreaks, and implementing timely interventions.
The Challenge: Identifying Disease Outbreaks Early
Detecting the presence of infectious diseases in a community can be challenging using traditional methods. Often, symptoms manifest only when a significant portion of the population is affected, making early intervention difficult. Wastewater testing, however, offers a proactive approach. By analyzing human waste for traces of pathogens, it becomes possible to identify outbreaks at an early stage, even before individuals display symptoms.
The ONETest™ Advantage: Unmatched Accuracy and Speed
The ONETest™ is designed to excel in wastewater testing. It employs Fusion Genomics’ patented QuantumProbes (QPs) technology, which captures the genomes of all known and emerging upper respiratory viral pathogens, providing a comprehensive view of their prevalence within a community. The ONETest™ is a fully automated, using a standard laboratory robotic device that delivers precise results with fast turn-around-time.
Applications of the ONETest™ in Wastewater Testing
Early Warning System: The ONETest™ serves as an early warning system for infectious disease outbreaks. It can detect diseases such as COVID-19, influenza, and more, enabling health authorities to initiate containment measures promptly.
Tracking Variants: With its ability to identify novel pathogens, the ONETest™ is instrumental in monitoring the emergence of new variants.
Pilot Project at Toronto Pearson International Airport
Fusion Genomics Corporation successfully launched an innovative pilot project at Toronto Pearson International Airport, utilizing our proprietary ONETest™ to screen wastewater for infectious pathogens. This pioneering initiative was designed to facilitate the early detection of COVID-19 and a spectrum of other infectious diseases within the airport’s ecosystem.
The outcomes of this project were exceptional. Throughout its operation from October 2022 to March 2023, the ONETest™ consistently and accurately detected the presence of COVID-19 alongside a comprehensive range of respiratory viruses. The facility’s performance in identifying all known respiratory viruses prevalent during this period was impeccable. Notably, the detection of SARS-CoV-2 and its variants through our ONETest™ was in alignment with the concurrent sample testing results from the Public Health Agency of Canada. However, our ONETest™ provided a more extensive viral profile, offering insights into the full array of respiratory viruses present—a capability yet to be demonstrated by any other platform. This real-world example demonstrates the ONETest™’s potential to transform wastewater testing into a powerful tool for protecting communities’ health.
Our Impact: Public Health and Beyond
Fusion Genomics envisions the ONETest™ as a catalyst for proactive public health interventions. Beyond infectious disease monitoring, our technology has the potential to impact bioterrorism preparedness, antimicrobial resistance surveillance, and environmental health research.
Join the ONETest™ Revolution
Fusion Genomics invites you to join us in the journey of transforming wastewater testing into a powerful tool for protecting communities’ health. Contact us today to learn more about the ONETest™ and how it can be integrated into your public health initiatives.